SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Cybersecurity, defense and chips: AI reshapes Israel’s exit market

Former IAI chief's drone company sold to U.S. defense-tech group

After raising tens of millions, fintech PayEm acquired for just $500,000

Israeli startups raise more than $3 billion in June as AI investment frenzy accelerates

Buzz

Most popular

Daily

Weekly

1

Israel orders hundreds of radar systems designed to detect fiber-optic drones

2

Former $450 million Israeli cyber exit Argus to shut down

3

Qualcomm acquires Israeli cyber company SAM for more than $150 million

4

Cyber unicorn Aikido acquires Israeli startup Root for $70-$100 million

5

Israel tests Iron Dome and Iron Beam as integrated air defense system

Oncology

6 stories about Oncology

Sai Jasti, senior VP and head of data science and AI at Bayer; Ofer Sharon, MD, physician and CEO of OncoHost

“Younger people are getting cancer more and more. We have to make kinder medicines.”

14.12.25|Zachy Hennessey

As AI hype accelerates, oncology’s real progress is happening quietly, driven by data, regulation, and the slow work of making cancer treatment more precise and sustainable

Protai Founders

Protai adds $12 million to Seed round as it aims to build oncology drug discovery pipeline

The Israeli startup, which has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level, aims to better predict which patients will respond to a given drug as well as discover novel drug targets that were missed by genomic approaches

Nucleai raises $33 million for spatial biology drug development platform

22.03.22|Meir Orbach

The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs

אוהד ארזי מנכ"ל זברה מדיקל

Israel’s Zebra Medical Vision gets its first FDA clearance in oncology

28.07.20|James Spiro

The new approval marks the sixth time the medical imaging company has earned FDA clearance

Oncology Company Alpha Tau Raises $29 Million

06.09.18|Hezi Sternlicht

Alpha Tau’s cancer treatment technology uses alpha radiation to treat solid tumors with radiation particles that are released inside the tumor, killing the surrounding cells

סרטן ריאות גידול סרטני

Israeli Oncology Company Alpha Tau is Raising Funds

22.08.18|Hezi Sternlicht

Alpha Tau is in the last stages of raising an investment of several tens of millions of dollars